Dieter David
- SEC CIK
- 0002061438
Latest role at each company
- COLL COLLEGIUM PHARMACEUTICAL, INCEVP & General Counselas of Apr 3, 2026
Trades
Every Form 4 that lists Dieter David as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| COLLCOLLEGIUM PHARMACEUTICAL, INC | Mar 20, 2026 | Mar 18, 2026 | Dieter DavidEVP & General Counsel | SSaleCommon Stock | −13.98K | $34.92 | −$488.04K | 77.07K | −15.4% | SEC10b5-1 |
| COLLCOLLEGIUM PHARMACEUTICAL, INC | Mar 11, 2026 | Mar 9, 2026 | Dieter DavidEVP & General Counsel | SSaleCommon Stock | −6.22K | $36.65 | −$228.11K | 91.05K | −6.4% | SEC10b5-1 |